Articles Tagged With:
-
New Report on Research Integrity: Institutions Also Play a Role
It’s not just individual researchers who need to support scientific integrity. Institutions and environments also play important roles, says a new report from the National Academies of Sciences, Engineering, and Medicine.
-
Researchers Develop Three Strategies to Shorten Informed Consent Forms
One new study has an answer to overly long consent forms that might appeal to most people who work in human research protection: eliminate repetition.
-
Watch Out for ‘Toxic’ Studies When Adding New Hospital to HRPP
When WellSpan Health merged with a community hospital, an unexpected problem came to the attention of the human research protection program -- having to do with 17 open studies at the hospital joining the WellSpan Health system.
-
The Central IRB Rule Is Still On — For Now
Soon, all IRBs will need to be ready to contract with central IRBs on cooperative research studies. While many IRBs already participate in reliance agreements, they say it’s becoming more complex and will take time and practice to prepare organizations for the big change.
-
The Big Chill: IRB Critic Says Changes Fall Short
IRB Advisor asked Zachary M. Schrag, PhD, to weigh in on his past concerns in light of the revised changes to the Common Rule.
-
Social Research Exemptions and Common Rule: It’s Complicated
Social scientists, behavioral researchers, and their respective IRBs find themselves in the midst of a somewhat complicated debate about how and to what extent the Common Rule changes affect or exempt oversight of their endeavors by the Office of Human Research Protections.
-
Clinical Briefs
In this section: Effects of weight gain on the cardiovascular system; comparing sleep apnea treatments; and rhabdomyolysis brought on by exercise.
-
Edaravone Injection (Radicava)
The FDA has approved edaravone, the first new treatment for amyotrophic lateral sclerosis since the approval of riluzole more than 20 years ago.
-
Guillain-Barré Syndrome and Hepatitis E
Hepatitis E is the most common form of viral hepatitis worldwide and often is asymptomatic, but it is commonly associated with Guillain-Barré syndrome and Guillain-Barré variants.
-
Treatment of Chronic Fatigue/Myalgic Encephalitis Syndrome
Blockade of IL-1 activity with anakinra failed to reduce fatigue in patients with chronic fatigue syndrome.